153
ῌ῎
῏῍
Staphylococcus aureus 1)1)
1)
!2)"#3)
1)
$%&'
2)
$%'%()
3)
$%& *ICT +
*, 16 4 - 12 ./ , 16 8 - 16 .+
2002 7 - 2002 12 -01 10 2
Staphylococcus aureus 3
4 567 7 289:;< S. aureus 3/ 5 S.
aureus 1=>?/ @1!A4 7 2 S. aureus 9 5 23BCDEFG *B+ II H methicillin resistant S. aureus (MRSA)/ IJ 2
29BVII HKBIII H methicillin susceptible S. aureus (MSSA) 8LM4 BVII
HN3 S. aureus 9/ oxacillin (MPIPC) 1 4 8 mg/ml MIC 8 borderlineresistant S. aureus 8LM4 AA/ PCR 1O mecA penicillin binding protein2῍
(PBP2῍) 9P8LM4 Q/ 7 2 S. aureus R 20 N
@!A
pulsed-field gel electrophoresis (PFGE) STUV/ 20"WX#$9YZM?>3/
289 1 2@[\/ S. aureus "WX#$
9]^F_@`A4 5,a
S. aureus K
S. aureus 9/ bN1%&cO5
K3`d4 S. aureus 3O9/ efF_N@'g1()
A/ efF_N1O'ghi21j*cOk+3lm4
Key words: / borderline-resistant S. aureus, PCR (polymerase chain reaction),
PFGE (pulsed-field gel electrophoresis)/ nohi
p3q1>?/ 1980 r,st
/ @1(bKZJ/ %A@
- u . methicillin-resistant Staphylococcus
t&hiKZO5K<LO4 5
aureus(MRSA)9/v/1wq1xQM4yz89{
t/ &hi1B3C28LO4
|}0~<-?J/ &hi1
2Zb8LO
4 5 MRSA 9/ b-lactam
1), 2)
311A?4567
, (PBP2῍) @
&hiDE9/ FDE@G1
H1 ¡hi¢IJDEKA?/ £W/ KL
nohiDE@¤¥cO5K3¦28LO4
cO5K1J.@8cO5K39?>
MRSA 9nohi1JMNA/ 'ghi§Z
O4 59 b-lactam 3:z1>?<6
¨%A©ª@«A;ghi@O2cOt/
7
,3k+Zt/ MRSA 9 b-lactam 3b
noDEPQ3¬tO4 5nohi¢IK
;@Q3?<cO 4
A?9/ MN/ %A©
3)
Q/ Staphylococcus 9='Z1>?Ac
STU´µ (¶693ῌ8501) ·¸¹VW 89ῌ1
$%&'
TEL: 0853ῌ20ῌ2420
E-mail: smorikiºshimane-med.ac.jp
ª@«cOMN&'i/
MNZk+3lmO3/ ®KAhi¢I
9i%A©ª¯°@«Ahi8LO4
±'1>?/ b3O5K3LO4 5
b
²R19/ {|b>³
G»¼ Vol. 14
No. 3
2004. 25
154
tuvw=xy¸B=z{ ¹=º{|'=»}~'
2ῌ !(R1 OP_>/?PDx2 S. au-
!"#
reus !VgzMW2. kg&
$%&'()*+,-. $*/
kh!"DheXY!(D. X!
&04)1 232. )&456* MRSA 7
Z[21
. 89 :8;<=II ;>50$%3/
BC'+ PCR % PFGE !
-&05), 6)1 $*/$%3/?!%
(R1 PCR S. aureus P!g=k
#&. ;@* pulsed-field gel electro-
g W. g\]2. ^; DNA %21
phoresis (PFGE) &ABC@
Tokue /_¡2 mecA "
!%2+"D/*EE06)1 FG)*)*. !"D8)1 PCR ~g~k :
'H#$%&3/6* S. aureus '
¢N=£hmkh< !"D1 Y`
ED+()*C,IBC
U¤M 94¥ 30 alm¦§ 55¥ 30
!
-+21
a kh¢c 72¥ 60 a! 35 ~kg(R
1 PCR . 1¨ fh!"Dbu©
cF]. ª}
2002 , 7 J3/ 2002 , 12 J? BacT/ALERT
%# 1,339 bp e!«[f521
3D :-.KLMN< "OP/01Q26*3
&3/. S. aureus 4ED++!
=oed5e
PFGE ªh= :-. BIO-RAD< !
"D. P&/?5/0]. ge!2.
(R1 $S?OP/0T5U% 540 U
lysozyme/lysostaphin gh. 50¥ 5 proteinase K
5. VWX 75 U&OP/0650R1 V2+.
gh. ij. 25¥ 5 SmaI gh]. 1¨ bu©
10 43/ S. aureus &6*&. 3 4OP
c" agarose kl] CHEF-DRIII :-. BIO-RAD<
/03/Y S. aureus &6*1 OPZ[$
!"D+. b¬ 6.0 v/cm, gh? 5.3 3/ 34.9
%&3/\ S. aureus &6*. 7 4ED
a. bu©c? 20.0 ?`U5bu©c21 V
++21 S. aureus 4ED+. 7] 1 8
2+. ª}
?Z93&:;,IV*/&3/ S.
21
=oed]«[f5®
aureus &6*+D3<3!^21 S. aureus BacT/ALERT 3D 56!=2/0
13//0P!Q22. OP_>/? :`abC<.
1)
S. au-
c8d_>/?. eMfghi@/? :-
reus 7 .jklmn< ,Iogp HK _>
#$%&'()*+
!"
/? :qABrs< /?5tu. Cvfh,Iw
7 43/6* 20 >mn%
u/0Dx!EyF>ED+. z9{
,I8=;!=2 :U 1<1 7 4o8=
|. VITEK AMS :-.KLMN< ,I8
II ; 5 4 14 >. MPIPC O2+ 16 mg/ml 9{|"}~ `a :`abC< !"
-¯D MIC !=2. °¤¢M±. p
D89{|!(D S. aureus %21
°¦
±. zg
±. ±,Ike±#²
. NCCLS !G
7) 2*HP
+p50R1 232. 4 3 3/6* 3 >
&I!!"D MIC-2000 :Js< 5
clindamycin (CLDM) 0.13 mg/ml Z MIC
KDxLMN (MIC) !y. oxacillin (MPIPC) 50R1 'q. vancomycin (VCM) #²+
O# MIC 3/ 2 mg/ml Z! methicillin-suscep-
50R1 8=;8=II ;& 5 4%8=VII
tible S. aureus (MSSA) %2 4 mg/ml ZP! MRSA
;,I8=III ;&V*³* 1 450R1 .
%21 . 'H#VQ& 3/ S.
OP/03/6* S. aureus 8=;%. OP
aureus &6*+D%. V>!"D+
Z[$%&3/6* S. aureus 8=;
P%R,Ioe}"8
´4?5#²+'50R1 7 4WX 4 4
9;"SOT :lza< !"DU;
IVH zgrs3/\ S. aureus &
!(R1 . MPIPC O2+ 0.5 mg/ml Z
6*&. µ- 3 43/ IVH zg
3/ 8 mg/ml MIC !=2'H# 4 >E
rs&36*+D
3R1 . OP¶·
D+ MRSA-LA a :lza< !"D+ PBP
3/ S. aureus &6* 3 4 1 >& MRSA
26 -.()*C¼
Vol. 14
No. 3
2004.
G@ABud
CCDE! S. aureus -.V#@ABV#6x2
1
155
CCDE!efgh2@AB[*jk
1
' F G
H I J
IVHMN
OPQR
4
8
0.5
4
0.13
0.13
0.13
0.13
2
' F G
16
16
8
8
32 32 32 32 32 16 8
32 32 32 32 32 16 8
8
8
3
'FG (8/ 9) 16
'FG (8/13) 16
H I J
16
8
8
8
32 32 32 32 32 16 8 0.13 8
32 32 32 32 32 16 8 0.13 8
32 32 32 32 32 16 8 0.13 8
4
FGz% 16
FG{% 16
IVHMN
16
8
8
8
32 32 32 32 32
32 32 8 32 32
32 32 32 32 32
8
8
16
8
8
8
4
4
4
MPIPC ABPC
CEZ
EM CLDM OFLX MINO AMK VCM CTM CMZ CZX FMOX IPM
0.25
0.25
0.25
0.25
1
8
1
1
1
4
4
4
4
4
2
2
0.5
0.5
0.5
0.5
0.06
0.06
0.06
0.06
0.5 0.13 0.5 0.25
0.5 0.25 0.5 0.25
0.5 0.13 0.5 0.25
0.5 0.13 0.5
8
4
4
4
4
4
4
1
1
1
1
VII
VII
VII
VII
4
8
8
4
1
2
II
II
2
4
2
4
4
2
1
1
1
II
II
II
8
8
8
8
8
8
8
8
8
1
1
1
II
II
II
5
F G
m
16
16
8
8
32 32 32 32 32
32 32 32 32 32
16
16
8
8
4
4
8
8
8
8
4
4
1
1
II
II
6
' F G
F G
IVHMN
16
16
16
16
8
8
8
8
32
32
32
32
32
32
32
32
16
16
16
16
8
8
8
8
4
4
4
4
8
8
8
8
8
8
8
8
16
32
16
8
1
2
2
1
II
II
II
II
7
F G
IVHMN
1
0.5
8
4
1
1
1
1
0.5 0.06 0.5 0.13 0.5 0.25 1
0.5 0.06 0.5 0.13 0.5 0.25
2
1
1
III
III
32 32
32 32
32 32
32 32
4
1
4
2
32
32
32
32
( mg/ml)
II 2 MSSA V 1 VII 1 2) 1 S. aureus 4 mecA
MPIPC 0.5 mg/ml 4 mg/ml 8
mg/ml MIC 1, 4 PCR ! PCR "#$%&'()*+
, 1 -./0 MRSA 12+34*5 1,339 bp 6789 mecA :+;<=>-.
/0 MSSA ?2+34*5 @AB 1 CDE!'FG HIJ IVH KL*L5MN@A
BOPQR 4 1,339 bp 6789:+;
<=S T MRSA-LA UVWX YZ[
L\]^_`abc?2 IVH KL*L5M
N MPIPC 0.5 mg/ml MIC > d'FG HIJ@ABOPQRCDE
! 3 efgh2Cijk MPIPC 89
MIC > 4l8 mg/ml m9 boderline-resistant
,1
1 CDE! S. aureus mecA
S. aureus no
3) 7 PFGE +;$%&'()*+ , 2 4 z
7 pq 4 rZ S. aureus 17 $%
% {%|}~\3DE!C9
&'()*+ stS9c u!v
> z%|}{%|}CDE!G/0
!ACDE!
@Z 8wxy:
S. aureus PFGE $%&'()*+ 3
-.V# Vol. 14
No. 3
2004. 27
±'²³e()´aµe¶· ¸e¹· "eº»¼"
156
¬2
_)W6
S. aureus 7 V
PFGE
MPIPC /LJ borderline resistant S. aureus IVH S. aureus #$8 * PCR +J mecA )W+$ PCR MRSA ,#7
!"#$
mecA )W6
F$8 ABC MRSA-LA
ῌ
@
PBP2ῌ +)WF$8 MSSA
῍
%&'()*+ NCCLS ,-./01
, Louie 11)
MPIPC /L57 MIC 2
MPIPC / 4 mg/ml 23 MIC +45 S. aureus
8 mg/ml mecA {( borderline resistant S.
MRSA ,6
7 8
4 mg/ml 23+45 S.
aureus 37 X)|xy MRSA borderline
aureus 9(:;
PBP < b-lactamase =
resistant S. aureus +/Q7qr
>?@ABC b-lactam DE<FGHI
mstu+J7 K)*8B1F
J73) K)*/AJ MPIPC /L
X/RS[ PQ PBP2ῌ +)W57q
J break point 4 mg/ml / 1 MNO 2 8
rmstuh
PCR JF:+
mg/ml MIC +4 MRSA MSSA ,/
\/ MRSA )W
P57 S. aureus /QGQRS57 TU V
1
#78#$
) W 6 4 X MPIPC / L 5 7 MIC
\/_ S. aureus 10 V
IVH )W6
1 X 0.5 mg/
)W6
1z 7 V
_2
ml 2Y Z[ 3 X
)` S. aureus )W6
12)
4 8 mg/ml \ MIC
_
#$ ]
]
K)*/J7%&'
()* ^_`abc MIC S. epidermidis, MRSA, Staphylococcus spp. ABC
MPIPC /L
Staphylococcus )W6
J 0.5 mg/ml 2Y MSSA #$ PCR mecA
MSSA /)WiJ7 j
)W6
deIV f heterogeneous MRSA +
MRSA ) W 6 V 86¡ MSSA gh PCR (+i9) j Nakatomi
70¡ /M
iJ7 £¤/AJ!! _d
klmnop`+&Dqrmstu
¢6
J8+
v MRSA PBP2ῌ +)W57)*+w
¥q¦{(§¨©/ª MRSA )
MPIPC /L57%&'(xy 232 X MRSA
W6
J7 TU ]
]
ghV
/A
1z 231 Xqrmstuv( Z[
J 7 V
« 4 V
/ IVH ¢6
1X
PCR mecA {()|xy+4 MRSA
)* 3 V
MRSA,
sm}~/qrmstuv(+i
1 V
MSSA )W6
8
_"#X
J710) TUghV
1 4 X1z 3 X
2)`)W6
S. aureus 1z
28 $%@&®¯° Vol. 14
No. 3
2004.
@A-#.''
S. aureus KLefg>-#.?fg>
II 5 14 3 157
\Gs$6D6HI"1S
3 11 MIC MIC O]^_!`a>3 MRSA N67( B8
15)
!"#$
KAb
%&
'
" 7 20 PFGE (
! ')*+,$-#.
"
ῌ
῏
2002 c 7
2002 c 12 Q"dc/@
A
S. aureus @A
/ MRSA 0"1& PFGE
WX
S. aureus 7 "/-
23&4567
20 +>$?!( KLefg
/289:+
>-#.?fg>'
; 4 -
<=
!"# IVH "#"4567
1)
7 5 K MRSA " 2 K
MSSA "1& MRSA 5 14
8ZII " MSSA 2 VII
S. aureus +-#.>$?"1&
ῌ"1& 7 @A"#'
'
S. aureus 8Z
"# S. aureus % Ma-
tsuda 13)&@A
"#''"
#(( @A
S. au-
reus
''"#)B"1&
"1&
2)
1 4 VII IVH 6hiWX 3 MPIPC [
*C Tenover 14) PFGE D7E
4 8 mg/ml borderline-resistant S. aureus
+FG,HI- '#D
"1&K mecA PBP2῎ K3&
7E.JK3LMNO67 2 3 D7E
MSSA %
PQ"/(R01S '+
FG,1 4 T=
!"# S. aureus
3)
PFGE 7 20 S. aureus Y4567
/(2R0KUV
4 WX
Y+>$?"8ZN
aureus ''
S. au-
@A
S.
O67UV
[34 \56A 73]
reus K1S"# S. aureus %
@A WX
S. aureus K
^_8[G9`^aV b$:;1&
cc
@A S. aureus K
@A
S. aureus Kj
^_g< NO67 S. aureus =h>
de^_ f]+-#.>$
?@
? S. aureus gg<<=h>?@
=h$R0K[ Gs$Z
K @A
MRSA
AB S. aureus ijC
9 MRSA ?B!HI"1
kK cKlmDnE-
S. aureus MRSA KF9op 60q70r *C1)
tuv
MRSA Gs$
8GwBxHI3yB"1 Q
X# Js^_"#zKL{M
S. aureus Kx8[2), 12) @A
S. aureus Kx8[
#S S. aureus K@ANOJ8
2)
Q3
"3UV
MRSA $|P}
mD1~_QR$"1
$|PS89?B_1$
_TcmD((&
UV(N
WX,YZ[KHI"1UV
Q
῎
῍
1) fg$:!*Ck 2000. l 11
cfmn~ I-10῍II-41. ¡mDo*¢
£¤p¥756
2) q¦r? 2002. KL!st
§
u¨
GwBῌKL{M
v^yB>wx
ῌ KLefg 29: 253῍260.
3) f©? 1991. MRSA yª« p. 78῍130,
MRSA $ 8 Z ¬ z { | }¡ m ®6¯° ~±
4) c² 2002. QR$ (1) ³´¢7yµ
¶E·¸B p. 100῍116, $[9
?¹J ³º» ~±
5)
¼ ? 2000. II !-L
29
<=>?tuvwx0ty! #tz!{ht|D}h
158
6)
7)
8)
9)
10)
1. Methicillin-resistant Staphylococcus aureus (MRSA). p. 40῍47, Yearbook 2000. 111 !"# 2002. $%&'( p. 12῍29, )
*+,-./01234 56789 :
;
National Committee for Clinical Laboratory
Standard. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that
grow aerobically Aproveded standardῌ5th ed.
M7-A5. NCCLS, Wayne, USA.
Tokue, Y., S. Shoji, A. Watanabe, et al. 1992.
Comparison of a polymerase chain reaction assay and a conventional microbiologic method
for detection of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
36: 6῍9.
<=>? @!AB CDEF G 1995. PCR
HIJ population analysis KILMNOPheterogeneous MRSA. 43: 487῍492.
Nakatomi, Y., J. Sugiyama. 1998. A rapid latex
11)
12)
13)
14)
15)
agglutination assay for the detection of penicillin-binding 2῎. Microbiol. Immunol. 42: 739῍
743.
Louie, L., O. S. Matsumura, E. Choi, et al. 2000.
Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus
aureus. J. Clin. Microb. 38: 2170῍2173.
QRST 2002. UVWXYZ [\]
29: 275῍277.
Matsuda, J., Y. Hirakata, F. Iori, et al. 1998.
Genetic relationship between blood and nonblood isolates from bacteremic patients determined by pulsed-field gel electrophoresis. J.
Clin. Microbiol. 36: 3081῍3084.
Tenover, C. F., D. R. Arbert, V. R. Goering, et al.
1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.
J. Clin. Microbiol. 33: 233῍2239.
:^_ ` 2000. a)*bcde p. 245῍
253, )*f ghi j kilmno pqr5
678sr Studies of Clinical Microbiology and Molecular Biology of Staphylococcus aureus
Isolated from Blood Culture and Non-blood Specimens of the Same Patients
Shoji Moriki,1) Akiko Nobata,1) Hiroshi Shibata,1)
Junichi Masuda2) and Shunichi Kumakura3)
1)
2)
Shimane University Hospital Central Clinical Laboratory
Shimane University School of Medicine Laboratory Medicine and Central Clinical Laboratory
3)
Shimane University Hospital Division of Blood Transfusion
From July to December 2002, we found 7 bacteremic patients who were positive for Staphylococcus
aureus in both blood and non-blood isolates. In total, 20 isolates were studied to examine the phenotypic
and genetic relationship between blood and non-blood isolates in each patient. Pattern of antibiograms and
the coagulase types of S. aureus from blood specimens were consistent with those from the non-blood
specimens in each patient. Two patients had MSSA, out of which borderline-resistant S. aureus was
identified in 1 case, and 5 patients had MRSA. Genetic analysis by pulsed-field gel electrophoresis (PFGE)
showed the same patterns between blood and non-blood specimens in individual cases.
However, in 1 case, di#erent PFGE patterns were observed between 2 blood isolates that were cultured
under aerobic and anaerobic conditions. Our present results indicate that S. aureus strains obtained from
blood and non-blood isolates were phenotypically and genetically identical in each patient, suggesting the
possibility that the same clone of S. aureus could be systemically expanded in cases of bacteremia caused
by this pathogen.
Key words: blood culture, borderline-resistant S. aureus, PCR (polymerase chain reaction), PFGE (pulsedfield gel electrophoresis), contact transmission
30
© Copyright 2024 Paperzz
